CXCR1/2 inhibition enhances pancreatic islet survival after transplantation

Journal of Clinical Investigation

Volumn 122, Issue 10, 2012, Pages 3647-3651

  Citro, Antonio ^a,b   Cantarelli, Elisa ^a   Maffi, Paola ^a   Nano, Rita ^a   Melzi, Raffaella ^a   Mercalli, Alessia ^a   Dugnani, Erica ^a   Sordi, Valeria ^a   Magistretti, Paola ^a   Daffonchio, Luisa ^c   Ruffini, Pier Adelchi ^c   Allegretti, Marcello ^c   Secchi, Antonio ^a,d   Bonifacio, Ezio ^e   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Research and Development Department   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; REPARIXIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; CHEMOKINE CXCL1; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EVALUATION, PRECLINICAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-8; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; NATURAL KILLER T-CELLS; NEUTROPHILS; PILOT PROJECTS; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84867188333     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63089     Document Type: Article

References (17)

1. Toyofuku A, et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes. 2006;55(1):34-39. (Pubitemid 43348456)
2. Yasunami Y, et al. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med. 2005;202(7):913-918. (Pubitemid 41398198)
3. Moberg L, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360(9350):2039-2045. (Pubitemid 36026584)
4. Johansson H, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes. 2005;54(6):1755-1762. (Pubitemid 40770765)
5. Melzi R, et al. Role of CCL2/MCP-1 in islet transplantation. Cell Transplant. 2010;19(8):1031-1046.
6. Piemonti L, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes. 2002;51(1):55-65. (Pubitemid 34517980)
7. Monti P, et al. Islet transplantation in patientswith autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest. 2008;118(5):1806-1814. (Pubitemid 351632383)
8. Hilbrands R, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes. 2009; 58(10):2267-2276.
9. Huurman VA, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One. 2008;3(6):e2435.
10. Lee J, Cacalano G, Camerato T, Toy K, Moore MW, Wood WI. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol. 1995;155(4):2158-2164.
11. Melzi R, Sanvito F, Mercalli A, Andralojc K, Bonifacio E, Piemonti L. Intrahepatic islet transplant in the mouse: functional and morphological characterization. Cell Transplant. 2008;17(12):1361-1370.
12. Fu W, Zhang Y, Zhang J, Chen WF. Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1. Cytokine. 2005;31(1):9-17. (Pubitemid 40828354)
13. Bertini R, et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci U S A. 2004;101(32):11791-11796. (Pubitemid 39095373)
14. Moberg L, Korsgren O, Nilsson B. Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. Clin Exp Immunol. 2005;142(1):125-131. (Pubitemid 41361015)
15. Matsuoka N, et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest. 2010; 120(3):735-743.
16. Greenbaum C, Seidel K, Pihoker C. The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes. Diabetes Care. 2004;27(5):1202-1204. (Pubitemid 38579791)
17. Caumo A, et al. Transplant estimated function: a simple index to evaluate beta-cell secretion after islet transplantation. Diabetes Care. 2008;31(2):301-305. (Pubitemid 351213340)